Factors affecting surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial.
about
Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance)Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance).Is there an Ideal Breast Conservation Rate for the Treatment of Breast Cancer?
P2860
Factors affecting surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Factors affecting surgical man ...... the NeoALTTO phase III trial.
@en
Factors affecting surgical man ...... the NeoALTTO phase III trial.
@nl
type
label
Factors affecting surgical man ...... the NeoALTTO phase III trial.
@en
Factors affecting surgical man ...... the NeoALTTO phase III trial.
@nl
prefLabel
Factors affecting surgical man ...... the NeoALTTO phase III trial.
@en
Factors affecting surgical man ...... the NeoALTTO phase III trial.
@nl
P2093
P2860
P356
P1433
P1476
Factors affecting surgical man ...... the NeoALTTO phase III trial.
@en
P2093
C Criscitiello
P2860
P304
P356
10.1093/ANNONC/MDU034
P577
2014-04-01T00:00:00Z